<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Infect Dis Obstet Gynecol</journal-id><journal-title>Infectious Diseases in Obstetrics and Gynecology</journal-title><issn pub-type="ppub">1064-7449</issn><issn pub-type="epub">1098-0997</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18476119</article-id><article-id pub-id-type="pmc">2364522</article-id>
        <article-id pub-id-type="pii">S1064744996000658</article-id>
        <article-id pub-id-type="doi">10.1155/S1064744996000658</article-id>
    <article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effect of Butoconazole Nitrate 2% Vaginal Cream and Miconazole Nitrate 2% Vaginal Cream 
      Treatments in Patients with Vulvovaginal Candidiasis</article-title></title-group><contrib-group>
        <contrib contrib-type="author" corresp="yes"><name><surname>Lappin</surname><given-names>Myra A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib>
        <contrib contrib-type="author"><name><surname>Brooker</surname><given-names>Doris C.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib>
        <contrib contrib-type="author"><name><surname>Francisco</surname><given-names>Carol A.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib>
        <contrib contrib-type="author"><name><surname>Dorfman</surname><given-names>Joan</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib>
    </contrib-group>
        <aff id="aff1"><label>1</label>
            <addr-line>Student Health Service</addr-line>
            <addr-line>San Francisco State University</addr-line>
            <addr-line>MS 4200</addr-line>
            <addr-line>1600 Holloway Avenue</addr-line>
            <addr-line>San Francisco</addr-line>
            <addr-line>CA</addr-line>
            <addr-line>94132-4200</addr-line>
            <country>USA</country>
        </aff>
        <aff id="aff2"><label>2</label>
            <addr-line>Department of Obstetrics and Gynecology</addr-line>
            <addr-line>University of Minnesota</addr-line>
            <addr-line>Minneapolis</addr-line>
            <addr-line>MN</addr-line>
            <country>USA</country>
        </aff>
        <aff id="aff3"><label>3</label>
            <addr-line>Department of Biostatistics</addr-line>
            <addr-line>Syntex Laboratories, Inc.</addr-line>
            <addr-line>Palo Alto</addr-line>
            <addr-line>CA</addr-line>
            <country>USA</country>
        </aff>
        <aff id="aff4"><label>4</label>
            <addr-line>Department of  Clinical Investigations</addr-line>
            <addr-line>Syntex Laboratories, Inc.</addr-line>
            <addr-line>Palo Alto</addr-line>
            <addr-line>CA</addr-line>
            <country>USA</country>
        </aff>
    <pub-date pub-type="ppub"><year>1996</year></pub-date><volume>4</volume><issue>6</issue><fpage>323</fpage><lpage>328</lpage><history><date date-type="received"><day>18</day><month>7</month><year>1996</year></date><date date-type="accepted"><day>14</day><month>1</month><year>1997</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 1996 Hindawi Publishing Corporation.</copyright-statement><copyright-year>1996</copyright-year><copyright-holder>Hindawi Publishing Corporation</copyright-holder><license license-type="open-access" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract>
        <p>In a multicenter, randomized, invesgtigator-blind, parallel study, 398 patients were dispensed topical
butoconazole nitrate 2% cream for 3 days (n = 199) or miconazole nitrate 2% cream for 7 days (n =
199) for vaginal use. Efficacy analyses included 254 patients with culture-confirmed <italic>Candida</italic> (119
butoconazole and 135 miconazole users). Of the 398 patients issued study medication, 9 were lost
to follow-up. Therefore, safety analyses included 389 patients (197 butoconazole and 192 miconazole
users). Evaluations upon admission and approximately 8 and 30 days post-treatment included
<italic>Candida</italic> cultures, potassium hydroxide (KOH) wet mounts, and vulvovaginal examinations, with
rating of vulvovaginal signs and symptoms using a 4-point scale. Rates of clinical cure (based on
sign/symptom scores), microbiologic cure (based on cultures and wet mounts), and therapeutic cure
(both clinical and microbiologic cures) were assessed and were to be similar between the regimens.
Therapeutic cure rates were 57.8% and 61.4% for butoconazole and miconazole, respectively.
Three-day butoconazole treatment was as safe and effective as 7-day miconazole therapy in treating
vulvovaginal candidiasis.</p>
    </abstract></article-meta></front></article>


